ARCHIVES

Pazdur Waxes On Calumet City And Krebiozen; Parkinson Takes Interim CMO Job at Zyngenia

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI

March 26, 2004

MacFarlane, Frelick to Speak At Seminar

July 22, 1983

FIT More Effective Than gFOBT In All Colonoscopy Capacities

November 25, 2011

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

Heart Institute Withdraws Sponsorship Of Breast Cancer Prevention Trial

October 27, 1995

No Justification Provided: AAUP Demands Reinstatement of Faculty Denied Tenure Renewal at MD Anderson

May 16, 2014